Charles Grob | Academic Influence

Charles Grob's AcademicInfluence.com Rankings

Charles Grob

Biology

#12367

World Rank

#15838

Historical Rank

#2630

USA Rank

biology Degrees

Download Badge

Biology

Charles Grob's Degrees

Bachelors Psychology University of Pennsylvania

Similar Degrees You Can Earn

Best Online Bachelor's in Psychology 2025

Why Is Charles Grob Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Charles Grob is a professor of Psychiatry & Biobehavioral Sciences and Pediatrics and director of the Division of Child and Adolescent Psychiatry at Harbor–UCLA Medical Center. He received his two BS degrees from Oberlin College and Columbia University, before getting an MD from the State University of New York, Downstate Medical Center. Grob's research interests include anxiety and mood disorders and also self-medication and substance abuse. The FDA approved one of his Phase 1 studies to study the psychological and physiological effects of MDMA and the hallucinogen ayahuasca.

(See a Problem?)

Charles Grob's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. (2011) (731)
Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil (1996) (290)
Pharmacokinetics of Hoasca alkaloids in healthy humans. (1999) (258)
Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response (2005) (207)
Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. (2005) (176)
An emergency department intervention for linking pediatric suicidal patients to follow-up mental health treatment. (2011) (174)
Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations (1995) (165)
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. (2016) (154)
Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca. (1996) (145)
Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. (1998) (120)
Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study (2000) (116)
PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program (2014) (109)
Phenomenology and Sequelae of 3,4-Methylenedioxymethamphetamine Use (1992) (105)
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study (2018) (103)
Report on Psychoactive Drug Use Among Adolescents Using Ayahuasca Within a Religious Context (2005) (99)
Cerebral 1H MRS alterations in recreational 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) users (1999) (96)
Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero (2001) (89)
Pediatric emergency department suicidal patients: two-site evaluation of suicide ideators, single attempters, and repeat attempters. (2008) (87)
Ayahuasca in Adolescence: A Preliminary Psychiatric Assessment (2005) (85)
Platelet serotonin uptake sites increased in drinkers ofayahuasca (1994) (77)
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults (2016) (72)
The Scientific Investigation of Ayahuasca: A Review of Past and Current Research (1999) (69)
Deconstructing Ecstasy: The Politics Of Mdma Research (2000) (64)
Neuropsychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy) in Recreational Users (2003) (62)
Ayahuasca in Adolescence: A Neuropsychological Assessment (2005) (58)
Hallucinogens and Redemption (2002) (55)
Effects of an Emergency Department Mental Health Intervention for Linking Pediatric Suicidal Patients to Follow-Up Mental Health Treatment: A Randomized Controlled Trial (2011) (54)
The Politics of Ecstasy (2002) (53)
Adolescent Drug Use in Cross-Cultural Perspective (1992) (46)
Hallucinogens as medicine. (2010) (46)
Sorted: Ecstasy facts and fiction. (2002) (42)
Psychogenic upper airway obstruction presenting as refractory wheezing. (1986) (38)
Is LSD toxic? (2018) (35)
Shamans, sacraments, and psychiatrists. (1989) (34)
A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation. (2006) (29)
Psychiatric Research with Hallucinogens: What have we learned? (2010) (29)
Ayahuasca in Adolescence: Qualitative Results (2005) (28)
Psychedelic medicine: safety and ethical concerns. (2020) (25)
Emotional and Behavioral Problems in Children With Learning Disabilities (1988) (25)
Suspected adverse methylphenidate-imipramine interactions in children. (1986) (24)
Use of the Classic Hallucinogen Psilocybin for Treatment of Existential Distress Associated with Cancer (2013) (24)
Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA (1997) (23)
Statement on ayahuasca. (2012) (22)
SINGLE CASE STUDY Female Exhibitionism (1985) (19)
The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs. (1992) (19)
MDMA research: preliminary investigations with human subjects (1998) (18)
Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity. (1990) (15)
Hallucinogens: A Reader (2002) (15)
Editors' Introduction: Ayahuasca Use in Cross-Cultural Perspective (2005) (15)
Do Drugs Have Religious Import? A 40-Year Retrospective (2004) (14)
Early Psychedelic Investigators Reflect on the Psychological and Social Implications of their Research (2006) (12)
Editors' Introduction: Hallucinogens at the Turn of the Century (1998) (12)
Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics (2005) (11)
Birthing the transpersonal (2008) (9)
Challenges in translational research: MDMA in the laboratory versus therapeutic settings (2021) (5)
Hallucinogens at the turn of the century: an introduction. (1998) (4)
Humanistic Psychology, Psychedelics, and the Transpersonal Vision (2017) (4)
The Shaman & Ayahuasca: Journeys To Sacred Realms (2011) (3)
Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines (2022) (3)
Ayahuasca use in cross-cultural perspective. (2005) (3)
Classic Psychedelics and Rational Suicide in the Elderly: Exploring the Potential Utility of a Reemerging Treatment Paradigm (2017) (3)
The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns. (2022) (3)
Psychedelics and the Western World A Fateful Marriage (2005) (3)
Where are the casualties (2002) (3)
Female exhibitionism. (1985) (2)
Interview with Jeffrey Bronfman, Representative Mestre for the Uniâo do Vegetal Church in the United States (2005) (2)
If the doors of perception were cleansed, would chronic pain be relieved? Evaluating the benefits and risks of psychedelics. (2022) (2)
Hallucinogens and Related Compounds (2012) (1)
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study (2018) (1)
Persistent supersensitivity vomiting following neuroleptic withdrawal in an adolescent (1986) (1)
Addressing the need for rigor in the rebirth of hallucinogen research (2017) (1)
Ayahuasca in adolescence: Qaualitative results. (2005) (1)
MDMA-Assisted Therapy : A New Treatment Paradigm for Autistic Adults with Social Anxiety (2015) (1)
Vine of the Soul: Medicine Men, Their Plants and Rituals in the Colombian Amazonia (1993) (0)
Repetitive Behavior (2021) (0)
The Oral History of Psychedelics Research Project, II: Do drugs have religious import? A forty year retrospective (2003) (0)
Psychedelic Research Resurrected: The Contributions of Stanislav Grof (2014) (0)
PW01-222 - Adolescents Using Hallucinogens Within A Religious Context: A Neuropsychological Assessment (2010) (0)
BReduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study^ (2018) (0)
6.3 CURRENT RESEARCH ON PSILOCYBIN TREATMENT ON END-OF-LIFE ANXIETY AND MDMA TREATMENT OF SOCIAL ANXIETY IN AUTISM SPECTRUM DISORDER (2021) (0)
The MDMA-neurotoxicity controversy (1992) (0)
19.2 Hoasca Use in Adolescents in a Brazilian Religious Community (2022) (0)
The Return of Psychedelics: A Measured Approach (2021) (0)
Taking Psychedelics Seriously (TH316) (2018) (0)
Hallucinogens: Spiritual and Therapeutic Use, Overuse, and Complications (2018) (0)

This paper list is powered by the following services:

Other Resources About Charles Grob

en.wikipedia.org

What Schools Are Affiliated With Charles Grob?

Charles Grob is affiliated with the following schools: